The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...
Dr Parthajit Das, director, Asian Institute of Immunology and Rheumatology Osteoporosis is a health condition characterised by low bone mineral density (BMD) and significant microarchitectural ...
Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...
Postmenopausal women with systemic sclerosis had a high prevalence of osteoporosis, which was linked to impaired quality of life and worse patient-reported outcomes. Osteoporosis is significantly more ...